A detailed history of Sunbelt Securities, Inc. transactions in Altimmune, Inc. stock. As of the latest transaction made, Sunbelt Securities, Inc. holds 2,374 shares of ALT stock, worth $19,110. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,374
Previous 1,140 108.25%
Holding current value
$19,110
Previous $7,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 18, 2024

BUY
$5.5 - $8.1 $6,787 - $9,995
1,234 Added 108.25%
2,374 $14,000
Q2 2024

Aug 15, 2024

BUY
$5.91 - $10.23 $6,737 - $11,662
1,140 New
1,140 $7,000

Others Institutions Holding ALT

About Altimmune, Inc.


  • Ticker ALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,025,300
  • Market Cap $395M
  • Description
  • Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...
More about ALT
Track This Portfolio

Track Sunbelt Securities, Inc. Portfolio

Follow Sunbelt Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sunbelt Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sunbelt Securities, Inc. with notifications on news.